4.7 Review

Canine tumors: a spontaneous animal model of human carcinogenesis

期刊

TRANSLATIONAL RESEARCH
卷 159, 期 3, 页码 165-172

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.trsl.2011.11.005

关键词

-

资金

  1. Portuguese Foundation for Science and Technology (FCT) [PTDC/CVT/65537/2006, PTDC/CVT/111358/2009]
  2. financiados no ambito do Programa Operacional Tematico Factores de Competitividade (COMPETE) e comparticipado pelo fundo Comunitario Europeu FEDER
  3. FCT [SFRH/BPD/63094/2009]
  4. Luso-American Foundation (FLAD)
  5. Fundação para a Ciência e a Tecnologia [PTDC/CVT/111358/2009, PTDC/CVT/65537/2006] Funding Source: FCT

向作者/读者索取更多资源

The enormous biologic complexity of human cancer has stimulated the development of more appropriate experimental models that could resemble in a natural and spontaneous manner the physiopathologic aspects of cancer biology. Companion animals have many desired characteristics that fill the gap between in vitro and in vivo studies, and these characteristics have proven to be important in understanding many complex molecular aspects of human cancer. Spontaneous tumors in dogs share a wide variety of epidemiologic, biologic, and clinical features with human cancer, which makes this animal model both attractive and underused in oncology research. In this review, we summarize the importance of naturally occurring canine tumors as valuable tools for studying numerous aspects of human cancer as well as the potential use of this animal model for the development of new cancer treatments. We address specifically the use of canine mammary tumors as an increasingly powerful model to study human breast cancer. (Translational Research 2012;159:165-172)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Biochemistry & Molecular Biology

Recent advances on smart glycoconjugate vaccines in infections and cancer

Marko Anderluh, Francesco Berti, Anna Bzducha-Wrobel, Fabrizio Chiodo, Cinzia Colombo, Federica Compostella, Katarzyna Durlik, Xhenti Ferhati, Rikard Holmdahl, Dragana Jovanovic, Wieslaw Kaca, Luigi Lay, Milena Marinovic-Cincovic, Marco Marradi, Musa Ozil, Laura Polito, Jose Juan Reina, Celso A. Reis, Robert Sackstein, Alba Silipo, Urban Svajger, Ondrej Vanek, Fumiichiro Yamamoto, Barbara Richichi, Sandra J. van Vliet

Summary: Vaccination is a major achievement in preventing infectious diseases, but challenges remain for pathogens with highly variable antigens and in inducing T-cell immunity in cancer. The recent outbreak also highlights the importance of designing smart therapeutic vaccines.

FEBS JOURNAL (2022)

Article Cell Biology

Rewired glycosylation activity promotes scarless regeneration and functional recovery in spiny mice after complete spinal cord transection

Joana Nogueira-Rodrigues, Sergio C. Leite, Rita Pinto-Costa, Sara C. Sousa, Liliana L. Luz, Maria A. Sintra, Raquel Oliveira, Ana C. Monteiro, Goncalo G. Pinheiro, Marta Vitorino, Joana A. Silva, Sonia Simao, Vitor E. Fernandes, Jan Provaznik, Vladimir Benes, Celia D. Cruz, Boris Safronov, Ana Magalhaes, Celso A. Reis, Jorge Vieira, Cristina P. Vieira, Gustavo Tiscornia, Ines M. Araujo, Monica M. Sousa

Summary: The spiny mouse is capable of spontaneous and fast restoration of function after severe spinal cord injury (SCI) due to the formation of scarless regenerative tissue. Transcriptomic analysis revealed the rewiring of glycosylation biosynthetic pathways in the spiny mouse, leading to pro-regenerative proteoglycan signature at the SCI site. This study highlights the importance of glycosylation switch in axon regeneration after SCI.

DEVELOPMENTAL CELL (2022)

Review Biochemistry & Molecular Biology

CAR-Ts: new perspectives in cancer therapy

Rafaela Abrantes, Henrique O. Duarte, Catarina Gomes, Sebastien Walchli, Celso A. Reis

Summary: The article translated introduces the principle and application of CAR-T cell therapy, pointing out its progress in the treatment of hematologic malignancies but challenges remain in the treatment of solid tumors. The article also discusses the limitations of CAR-T cell therapy and the current strategies to overcome these challenges, while proposing future prospects for further research.

FEBS LETTERS (2022)

Article Gastroenterology & Hepatology

Helicobacter species binding to the human gastric mucosa

Rita Matos, Hugo Santos Sousa, Jorge Nogueiro, Ana Magalhaes, Celso A. Reis, Fatima Carneiro, Irina Amorim, Freddy Haesebrouck, Fatima Gartner

Summary: The study shows that gastric non-Helicobacter pylori Helicobacter can bind to the human gastric mucosa, with a prevalence of chronic gastritis and chronic active gastritis among patients. Interestingly, these bacteria were found to bind to the gastric mucosa of individuals with severe chronic inflammation and intestinal metaplasia.

HELICOBACTER (2022)

Review Gastroenterology & Hepatology

Bringing to Light the Risk of Colorectal Cancer in Inflammatory Bowel Disease: Mucosal Glycosylation as a Key Player

Eduarda Leite-Gomes, Ana M. Dias, Catarina M. Azevedo, Beatriz Santos-Pereira, Mariana Magalhaes, Monica Garrido, Rita Amorim, Paula Lago, Ricardo Marcos-Pinto, Salome S. Pinho

Summary: Colitis-associated cancer is a major complication of inflammatory bowel disease, and the molecular mechanisms underlying its progression are still unclear. Protein glycosylation shows promise for improving our understanding of CAC immunopathogenesis and may open new avenues for clinical and therapeutic interventions.

INFLAMMATORY BOWEL DISEASES (2022)

Review Biochemistry & Molecular Biology

Phenylethyl Isothiocyanate: A Bioactive Agent for Gastrointestinal Health

Ezequiel R. Coscueta, Ana Sofia Sousa, Celso A. Reis, Maria Manuela Pintado

Summary: The incidence of gastrointestinal pathologies, particularly cancer, has been increasing, resulting in significant morbidity, mortality, and economic burden on the healthcare system. Natural phytochemicals, such as phenylethyl isothiocyanate (PEITC) found in cruciferous vegetables like watercress, have shown therapeutic and preventive effects on these diseases. PEITC possesses antioxidant, anti-inflammatory, bactericidal, and anticarcinogenic properties. This review provides an overview of the role of PEITC in the prevention and treatment of oxidative/inflammatory-related gastrointestinal disorders and discusses the safe and recommended dosage of PEITC. Moreover, it proposes a framework for sustainable methodologies to obtain and stabilize PEITC for industrial use. Further scientific studies are needed to develop PEITC products for the nutraceutical, pharmaceutical, or food industries.

MOLECULES (2022)

Review Oncology

Glycans as Targets for Drug Delivery in Cancer

Francisca Diniz, Pedro Coelho, Henrique O. Duarte, Bruno Sarmento, Celso A. Reis, Joana Gomes

Summary: Alterations in glycosylation are commonly observed in cancer cells. Strategies targeting cancer-associated glycans, such as monoclonal antibodies, antibody-drug conjugates, and nanoparticles, have the potential to improve drug delivery to tumor cells and enhance therapeutic efficacy. Nanoparticles can also be used for drug delivery in cancer therapy, including encapsulating vaccines and targeting glycoproteins or glycan-binding proteins. These strategies have significant potential for personalized treatment approaches in the pharmaceutical and clinical sectors.

CANCERS (2022)

Review Biochemistry & Molecular Biology

Glycans as a key factor in self and nonself discrimination: impact on the breach of immune tolerance

Ines Alves, Angela Fernandes, Beatriz Santos-Pereira, Catarina M. Azevedo, Salome S. Pinho

Summary: Glycans, carbohydrates covalently conjugated to other biomolecules, are crucial in defining the identity of a cell or an organism, as they cover the surface of human cells and pathogens. They can be recognized by glycan-binding proteins (GBP) expressed by immune cells, regulating both pro-inflammatory and anti-inflammatory responses. This review discusses how glycans modulate host-pathogen interactions and inflammatory processes, and highlights the potential of glycoscience research in providing valuable biomarkers and therapeutic targets for immunity.

FEBS LETTERS (2022)

Review Immunology

Glycans as shapers of tumour microenvironment: A sweet driver of T-cell-mediated anti-tumour immune response

Angela Fernandes, Catarina M. Azevedo, Mariana C. Silva, Guilherme Faria, Carolina S. Dantas, Manuel M. Vicente, Salome S. Pinho

Summary: Cells are covered with sugar chains called glycocalyx. Changes in cellular glycosylation are associated with cancer and affect tumor immune responses. Glycans play a crucial role in T-cell development, differentiation, activation, and signaling. The diverse glycans on the surface of T cells regulate the interactions between T cells and cancer cells, fine-tuning the anti-tumor immune response.

IMMUNOLOGY (2023)

Article Biotechnology & Applied Microbiology

Vancomycin-Loaded, Nanohydroxyapatite-Based Scaffold for Osteomyelitis Treatment: In Vivo Rabbit Toxicological Tests and In Vivo Efficacy Tests in a Sheep Model

Nuno Alegrete, Susana R. R. Sousa, Tatiana Padrao, Angela Carvalho, Raquel Lucas, Raphael F. F. Canadas, Catarina Lavrador, Nuno Alexandre, Fatima Gartner, Fernando J. J. Monteiro, Manuel Gutierres

Summary: The treatment for osteomyelitis usually involves surgical debridement, tissue coverage, and long-term administration of antibiotics. V-HEPHAPC, a composite material containing vancomycin, has shown promising results in vitro as a local antibiotic carrier and bone scaffold. In this study, V-HEPHAPC granules were successfully used to treat MRSA osteomyelitis in a sheep model.

BIOENGINEERING-BASEL (2023)

Article Biochemistry & Molecular Biology

ST3GalIV drives SLeX biosynthesis in gastrointestinal cancer cells and associates with cancer cell motility

Ana F. Costa, Emanuel Senra, Isabel Faria-Ramos, Andreia Teixeira, Joao Morais, Mariana Pacheco, Celso A. Reis, Catarina Gomes

Summary: Expression of SLeX is associated with malignant transformation of cancer cells and their invasive properties. In this study, the role of ST3GalIV in the biosynthesis of SLeX and malignant properties of GI cancer cells was investigated. The findings suggest that ST3GalIV is the main enzyme driving the biosynthesis of SLeX and affects cancer cell motility.

GLYCOCONJUGATE JOURNAL (2023)

Article Multidisciplinary Sciences

Syndecan-4 is a maestro of gastric cancer cell invasion and communication that underscores poor survival

Juliana Pocas, Catarina Marques, Catarina Gomes, Andreia Hanada Otake, Filipe Pinto, Mariana Ferreira, Tiago Silva, Isabel Faria-Ramos, Rita Matos, Ana Raquel Ribeiro, Emanuel Senra, Bruno Cavadas, Silvia Batista, Joana Maia, Joana A. Macedo, Luis Lima, Luis Pedro Afonso, Jose Alexandre Ferreira, Lucio Lara Santos, Antonio Polonia, Hugo Osorio, Mattias Belting, Celso A. Reis, Bruno Costa-Silva, Ana Magalhaes

Summary: Gastric cancer is influenced by the expression of syndecan-4 (SDC4) which is associated with poor patient survival. SDC4 plays a crucial role in regulating the motility and invasion of gastric cancer cells. Additionally, SDC4 decorated with heparan sulfate is involved in the distribution, uptake, and functional effects of extracellular vesicles (EVs) derived from gastric cancer cells. SDC4 knockout disrupts the tropism of EVs for common gastric cancer metastatic sites. These findings provide insight into the molecular implications of SDC4 expression in gastric cancer cells and present potential therapeutic strategies targeting the glycan-EV axis to limit tumor progression.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

Article Chemistry, Multidisciplinary

Differential Protein and Glycan Packaging into Extracellular Vesicles in Response to 3D Gastric Cancer Cellular Organization

Alvaro M. Martins, Tania M. Lopes, Francisca Diniz, Jose Pires, Hugo Osorio, Filipe Pinto, Daniela Freitas, Celso A. Reis

Summary: Alterations in glycosylation machinery in cancer cells lead to the synthesis of abnormal glycan structures in tumor cells. Extracellular vesicles (EVs) are involved in cancer communication and progression, and certain tumor-associated glycans have been identified in cancer EVs. This study investigates the impact of 3D tumor architecture on the selective packaging of cellular glycans into EVs. The results show differential packaging of specific proteins and glycans in EVs produced by 2D and 3D cultured cells, suggesting distinct biological functions and correlation with clinical data.

ADVANCED SCIENCE (2023)

Review Immunology

Glycome dynamics in T and B cell development: basic immunological mechanisms and clinical applications

Manuel M. Vicente, Eduarda Leite-Gomes, Salome S. Pinho

Summary: Gly-cosylation is the process by which glycans cover the surfaces of mammalian cells. The immune system's pathways are regulated by glycosylation, with most proteins and receptors involved in this process. This article discusses the hypothesis that the development of T and B cells is tightly regulated by glycome composition, and explores the fundamental roles of glycans in lymphocyte development and their impact on the functionality of T and B cells in adaptive immunity. These findings could lead to the discovery of new disease factors and more effective treatments.

TRENDS IN IMMUNOLOGY (2023)

Review Oncology

Insights on ErbB glycosylation - contributions to precision oncology

Henrique O. Duarte, Celso A. Reis, Joana Gomes

Summary: Studying the site-specific glycome of ErbB receptors is of great importance for designing more efficient ErbB-directed therapeutic strategies, establishing new clinical biomarkers, and guiding therapeutic decisions.

TRENDS IN CANCER (2022)

暂无数据